[CARA] Cara Therapeutics, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 135.31 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 9.97 Change: 0.77 (8.37%)
Ext. hours: 10.13 Change: 0.16 (1.6%)

chart CARA

Refresh chart

Strongest Trends Summary For CARA

CARA is in the long-term up 162% in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Its lead product candidate includes intravenous CR845, which has completed Phase II clinical trials for the treatment acute postoperative pain in adult patients. The company is also developing Oral CR845 that has completed Phase I clinical trial for the treatment of moderate-to-severe acute and chronic pain; and CR701, which is in preclinical trial for treating neuropathic and inflammatory pain. Cara Therapeutics, Inc. was founded in 2004 and is based in Shelton, Connecticut.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding27.28 M EPS-2.52 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -49.06% Sales Growth - Q/Q-46.5% P/E-6.79
P/E To EPS Growth P/S38.79 P/BV2.85 Price/Cash Per Share
Price/Free Cash Flow ROA-36.88% ROE-40.17% ROI
Current Ratio14.31 Quick Ratio Long Term Debt/Equity Debt Ratio0.07
Gross Margin Operating Margin-555.3% Net Profit Margin-546.19% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities10 K Cash From Investing Activities-10 K Cash From Operating Activities-5.24 M Gross Profit
Net Profit-4.69 M Operating Profit-4.72 M Total Assets51.65 M Total Current Assets49.06 M
Total Current Liabilities3.43 M Total Debt800 K Total Liabilities4.23 M Total Revenue490 K
Technical Data
High 52 week23.95 Low 52 week11.6 Last close17.14 Last change1.12%
RSI68.79 Average true range0.75 Beta1.58 Volume1.26 M
Simple moving average 20 days6.82% Simple moving average 50 days13.42% Simple moving average 200 days-3.25%
Performance Data
Performance Week0.53% Performance Month14.5% Performance Quart-3.44% Performance Half-8.34%
Performance Year23.58% Performance Year-to-date31.85% Volatility daily2.8% Volatility weekly6.27%
Volatility monthly12.84% Volatility yearly44.49% Relative Volume252.99% Average Volume616.94 K
New High New Low

News

2019-06-02 09:09:00 | Is Cara Therapeutics a Buy Now?

2019-05-31 07:00:00 | Cara Therapeutics to Present at the Jefferies 2019 Healthcare Conference

2019-05-30 07:48:11 | Cara Shares Up on Positive Phase III Data for Itchiness Drug

2019-05-29 14:30:00 | Cara Therapeutics Surges on Phase 3 Results for Itchiness Treatment

2019-05-29 13:13:47 | Stocks making the biggest moves midday: Canada Goose, Capri Holdings, General Mills & more

2019-05-29 11:48:56 | Cara Therapeutics Rallies On Positive Clinical Readout For Pruritis Drug

2019-05-29 11:36:08 | Why Cara Therapeutics Stock Is Soaring Today

2019-05-29 10:39:55 | Understanding Medical Cannabis vs. Recreational Cannabis Stocks

2019-05-29 09:36:06 | Announcing: Cara Therapeutics NASDAQ:CARA Stock Increased An Energizing 193% In The Last Three Years

2019-05-29 09:23:00 | Cara Therapeutics surges 15.7% after company announces positive late-stage data for itchiness treatment

2019-05-29 09:02:00 | Cara Therapeutics stock up 12.6% after company announces positive Phase 3 data for itchiness treatment

2019-05-29 07:00:00 | Cara Therapeutics Announces Positive Results From KALM-1 Pivotal Phase 3 Trial of KORSUVA™ Injection in Hemodialysis Patients with Pruritus

2019-05-29 06:00:00 | 3 Top Small-Cap Stocks to Buy Right Now

2019-05-28 10:43:12 | 3 ‘Strong Buy’ Cannabis Biotech Stocks To Know Now

2019-05-23 07:10:39 | Even with a Pharma Arm, Canopy Growth Stock Is About Recreational Use

2019-05-17 06:00:00 | 3 Small-Cap Biotech Stocks You Can Buy Right Now

2019-05-09 13:12:06 | Did Hedge Funds Drop The Ball On Casa Therapeutics Inc CARA ?

2019-05-08 23:12:49 | Edited Transcript of CARA earnings conference call or presentation 7-May-19 8:30pm GMT

2019-05-08 16:01:00 | Cara Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

2019-05-08 14:23:30 | Cara Therapeutics Inc CARA Q1 2019 Earnings Call Transcript

2019-05-07 18:25:10 | Cara Therapeutics CARA Reports Q1 Loss, Lags Revenue Estimates

2019-05-07 17:15:25 | Cara: 1Q Earnings Snapshot

2019-05-07 16:01:00 | Cara Therapeutics Reports First Quarter 2019 Financial Results

2019-05-07 13:20:02 | Key Cannabis Sector Updates: Analyst Ratings and Earnings

2019-05-07 11:45:50 | Cannabis Stocks Had a Mixed Performance Last Week

2019-05-06 08:52:12 | Implied Volatility Surging for Cara Therapeutics CARA Stock Options

2019-04-30 16:01:00 | Cara Therapeutics to Announce First Quarter 2019 Financial Results on May 7, 2019

2019-04-29 12:05:22 | Ups and Downs in the Cannabis Space Last Week

2019-04-29 09:30:18 | Are There Cannabis Stocks in Your Portfolio? Here’s the Straight Dope

2019-04-22 13:43:44 | Cannabis Updates: New Listings, Price Action, and Ratings

2019-04-16 08:30:00 | CBD Company to Research Now

2019-04-14 14:00:00 | Better Buy: GW Pharmaceuticals vs. Cara Therapeutics

2019-04-11 07:50:00 | Cara Therapeutics Posts 2018 Revenue 15X over 2017, Questions, Catalysts, and Hurdles Every Marijuana Stock Investor Should be Considering

2019-04-09 08:40:00 | Why Cara Therapeutics Stock Jumped 15.1% in March

2019-04-08 10:00:00 | 3 Top Biotech Stocks to Buy in April

2019-04-07 14:00:00 | 3 Top Small-Cap Biotech Stocks for Aggressive Investors

2019-04-02 16:01:00 | Cara Therapeutics to Present at the 18th Annual Needham Healthcare Conference

2019-04-02 09:35:25 | Analysts Love Charlotte’s Web Holdings despite Q4 Earnings Miss

2019-03-29 09:40:13 | Charlotte’s Web Holdings Reports Record Harvest in 2018

2019-03-29 07:20:00 | Analysis: Positioning to Benefit within American Water Works, TripAdvisor, ACADIA Pharmaceuticals, Dril-Quip, Domtar, and Cara Therapeutics — Research Highlights Growth, Revenue, and Consolidated Results

2019-03-26 08:05:05 | Charlotte’s Web Holdings Is Outperforming Peers in March

2019-03-22 13:00:00 | Cannabis Breakout Candidates - THC Therapeutics, Inc. THCT

2019-03-13 21:50:08 | Edited Transcript of CARA earnings conference call or presentation 12-Mar-19 8:30pm GMT

2019-03-13 13:01:47 | Here's Why Cara Therapeutics Stock Rose as Much as 13.9% Today

2019-03-13 12:15:00 | These Four Marijuana Stocks Are Raising Eyebrows on Wednesday

2019-03-13 00:19:42 | Cara Therapeutics Inc CARA Q4 2018 Earnings Conference Call Transcript

2019-03-12 17:35:01 | Stocks making the biggest moves after hours: Switch, Clearwater Paper and more

2019-03-12 17:20:09 | Cara Therapeutics CARA Reports Q4 Loss, Tops Revenue Estimates

2019-03-12 16:27:34 | Cara: 4Q Earnings Snapshot

2019-03-12 16:01:00 | Cara Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results